Cargando…
When Should Children with HIV Infection Be Started on Antiretroviral Therapy?
Background to the debate: The advent of highly active antiretroviral therapy (HAART) dramatically improved the prognosis for both adults and children infected with HIV who had access to treatment. However, the optimal timing for initiating treatment remains controversial, particularly in children. T...
Autores principales: | , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2270305/ https://www.ncbi.nlm.nih.gov/pubmed/18366251 http://dx.doi.org/10.1371/journal.pmed.0050073 |
_version_ | 1782151727382790144 |
---|---|
author | Welch, Steven B Gibb, Di |
author_facet | Welch, Steven B Gibb, Di |
author_sort | Welch, Steven B |
collection | PubMed |
description | Background to the debate: The advent of highly active antiretroviral therapy (HAART) dramatically improved the prognosis for both adults and children infected with HIV who had access to treatment. However, the optimal timing for initiating treatment remains controversial, particularly in children. This debate lays out the case for deferred treatment against the case for early initiation of HAART in children. |
format | Text |
id | pubmed-2270305 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2008 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-22703052008-03-20 When Should Children with HIV Infection Be Started on Antiretroviral Therapy? Welch, Steven B Gibb, Di PLoS Med The PLoS Medicine Debate Background to the debate: The advent of highly active antiretroviral therapy (HAART) dramatically improved the prognosis for both adults and children infected with HIV who had access to treatment. However, the optimal timing for initiating treatment remains controversial, particularly in children. This debate lays out the case for deferred treatment against the case for early initiation of HAART in children. Public Library of Science 2008-03 2008-03-25 /pmc/articles/PMC2270305/ /pubmed/18366251 http://dx.doi.org/10.1371/journal.pmed.0050073 Text en Copyright: © 2008 Welch and Gibb. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | The PLoS Medicine Debate Welch, Steven B Gibb, Di When Should Children with HIV Infection Be Started on Antiretroviral Therapy? |
title | When Should Children with HIV Infection Be Started on Antiretroviral Therapy? |
title_full | When Should Children with HIV Infection Be Started on Antiretroviral Therapy? |
title_fullStr | When Should Children with HIV Infection Be Started on Antiretroviral Therapy? |
title_full_unstemmed | When Should Children with HIV Infection Be Started on Antiretroviral Therapy? |
title_short | When Should Children with HIV Infection Be Started on Antiretroviral Therapy? |
title_sort | when should children with hiv infection be started on antiretroviral therapy? |
topic | The PLoS Medicine Debate |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2270305/ https://www.ncbi.nlm.nih.gov/pubmed/18366251 http://dx.doi.org/10.1371/journal.pmed.0050073 |
work_keys_str_mv | AT welchstevenb whenshouldchildrenwithhivinfectionbestartedonantiretroviraltherapy AT gibbdi whenshouldchildrenwithhivinfectionbestartedonantiretroviraltherapy |